Top

Journal of Neuroinflammation

Published in:

Open Access 01-12-2011 | Research

Cooperative contributions of Interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells

Authors: Makoto Horiuchi, Aki Itoh, David Pleasure, Keiko Ozato, Takayuki Itoh

Published in: Journal of Neuroinflammation | Issue 1/2011

Abstract

Background

Administration of exogenous interferon-γ (IFNγ) aggravates the symptoms of multiple sclerosis (MS), whereas interferon-β (IFNβ) is used for treatment of MS patients. We previously demonstrated that IFNγ induces apoptosis of oligodendroglial progenitor cells (OPCs), suggesting that IFNγ is more toxic to OPCs than IFNβ. Thus we hypothesized that a difference in expression profiles between IFNγ-inducible and IFNβ-inducible genes in OPCs would predict the genes responsible for IFNγ-mediated cytotoxic effects on OPCs. We have tested this hypothesis particularly focusing on the interferon regulatory factors (IRFs) well-known transcription factors up-regulated by IFNs.

Methods

Highly pure primary rat OPC cultures were treated with IFNγ and IFNβ. Cell death and proliferation were assessed by MTT reduction, caspse-3-like proteinase activity, Annexin-V binding, mitochondrial membrane potential, and BrdU-incorporation. Induction of all nine IRFs was comprehensively compared by quantitative PCR between IFNγ-treated and IFNβ-treated OPCs. IRFs more strongly induced by IFNγ than by IFNβ were selected, and tested for their ability to induce OPC apoptosis by overexpression and by inhibition by dominant-negative proteins or small interference RNA either in the presence or absence of IFNγ.

Results

Unlike IFNγ, IFNβ did not induce apoptosis of OPCs. Among nine IRFs, IRF1 and IRF8 were preferentially up-regulated by IFNγ. In contrast, IRF7 was more robustly induced by IFNβ than by IFNγ. Overexpressed IRF1 elicited apoptosis of OPCs, and a dominant negative IRF1 protein partially protected OPCs from IFNγ-induced apoptosis, indicating a substantial contribution of IRF1 to IFNγ-induced OPC apoptosis. On the other hand, overexpression of IRF8 itself had only marginal proapoptotic effects. However, overexpressed IRF8 enhanced the IFNγ-induced cytotoxicity and the proapoptotic effect of overexpressed IRF1, and down-regulation of IRF8 by siRNA partially but significantly reduced preapoptotic cells after treatment with IFNγ, suggesting that IRF8 cooperatively enhances IFNγ-induced OPC apoptosis.

Conclusions

This study has identified that IRF1 and IRF8 mediate IFNγ-signaling leading to OPC apoptosis. Therapies targeting at these transcription factors and their target genes could reduce IFNγ-induced OPC loss and thereby enhance remyelination in MS patients.

Available only for authorised users

Watanabe M, Hadzic T, Nishiyama A: Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia. 2004, 46: 311-322. 10.1002/glia.20006.CrossRefPubMed

Islam MS, Tatsumi K, Okuda H, Shiosaka S, Wanaka A: Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem Int. 2009, 54: 192-198. 10.1016/j.neuint.2008.10.011.CrossRefPubMed

Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol. 2002, 31: 523-536. 10.1023/A:1025747832215.CrossRefPubMed

Agresti C, D'Urso D, Levi G: Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci. 1996, 8: 1106-1116. 10.1111/j.1460-9568.1996.tb01278.x.CrossRefPubMed

Andrews T, Zhang P, Bhat NR: TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res. 1998, 54: 574-583. 10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0.CrossRefPubMed

Balabanov R, Strand K, Kemper A, Lee JY, Popko B: Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. J Neurosci. 2006, 26: 5143-5152. 10.1523/JNEUROSCI.0737-06.2006.CrossRefPubMed

Chew LJ, King WC, Kennedy A, Gallo V: Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells. Glia. 2005, 52: 127-143. 10.1002/glia.20232.CrossRefPubMed

Lin W, Harding HP, Ron D, Popko B: Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol. 2005, 169: 603-612. 10.1083/jcb.200502086.PubMedCentralCrossRefPubMed

Vartanian T, Li Y, Zhao M, Stefansson K: Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med. 1995, 1: 732-743.PubMedCentralPubMed

10.

Horiuchi M, Itoh A, Pleasure D, Itoh T: MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells. J Biol Chem. 2006, 281: 20095-20106. 10.1074/jbc.M603179200.CrossRefPubMed

11.

Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L: The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews. Clinical neurology and neurosurgery. 2008, 110: 878-885. 10.1016/j.clineuro.2007.10.020.CrossRefPubMed

12.

Halfpenny CA, Scolding NJ: Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro. J Neuroimmunol. 2003, 139: 9-16. 10.1016/S0165-5728(03)00125-5.CrossRefPubMed

13.

Heine S, Ebnet J, Maysami S, Stangel M: Effects of interferon-beta on oligodendroglial cells. J Neuroimmunol. 2006, 177: 173-180. 10.1016/j.jneuroim.2006.04.016.CrossRefPubMed

14.

Trebst C, Heine S, Lienenklaus S, Lindner M, Baumgartner W, Weiss S, Stangel M: Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination. Acta Neuropathol. 2007, 114: 587-596. 10.1007/s00401-007-0300-z.CrossRefPubMed

15.

Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005, 5: 375-386. 10.1038/nri1604.CrossRefPubMed

16.

Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol. 1997, 15: 749-795. 10.1146/annurev.immunol.15.1.749.CrossRefPubMed

17.

Itoh T, Horiuchi M, Itoh A: Interferon-triggered transcriptional cascades in the oligodendroglial lineage: a comparison of induction of MHC class II antigen between oligodendroglial progenitor cells and mature oligodendrocytes. J Neuroimmunol. 2009, 212: 53-64. 10.1016/j.jneuroim.2009.04.021.PubMedCentralCrossRefPubMed

18.

Wang Y, Ren Z, Tao D, Tilwalli S, Goswami R, Balabanov R: STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells. Glia. 2010, 58: 195-208. 10.1002/glia.20912.CrossRefPubMed

19.

Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 1989, 58: 729-739. 10.1016/0092-8674(89)90107-4.CrossRefPubMed

20.

Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T: Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 1988, 54: 903-913. 10.1016/S0092-8674(88)91307-4.CrossRefPubMed

21.

Taniguchi T, Ogasawara K, Takaoka A, Tanaka N: IRF family of transcription factors as regulators of host defense. Annu Rev Immunol. 2001, 19: 623-655. 10.1146/annurev.immunol.19.1.623.CrossRefPubMed

22.

Honda K, Taniguchi T: IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006, 6: 644-658. 10.1038/nri1900.CrossRefPubMed

23.

Ozato K, Tailor P, Kubota T: The interferon regulatory factor family in host defense: mechanism of action. J Biol Chem. 2007, 282: 20065-20069. 10.1074/jbc.R700003200.CrossRefPubMed

24.

Tamura T, Yanai H, Savitsky D, Taniguchi T: The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol. 2008, 26: 535-584. 10.1146/annurev.immunol.26.021607.090400.CrossRefPubMed

25.

Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T: Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 1999, 18: 5028-5041. 10.1093/emboj/18.18.5028.PubMedCentralCrossRefPubMed

26.

Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T: Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 1990, 63: 303-312. 10.1016/0092-8674(90)90163-9.CrossRefPubMed

27.

Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T: Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 1993, 259: 971-974. 10.1126/science.8438157.CrossRefPubMed

28.

Agresti C, Bernardo A, Del Russo N, Marziali G, Battistini A, Aloisi F, Levi G, Coccia EM: Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. Eur J Neurosci. 1998, 10: 2975-2983. 10.1111/j.1460-9568.1998.00313.x.CrossRefPubMed

29.

Itoh T, Beesley J, Itoh A, Cohen AS, Kavanaugh B, Coulter DA, Grinspan JB, Pleasure D: AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem. 2002, 81: 390-402. 10.1046/j.1471-4159.2002.00866.x.CrossRefPubMed

30.

Moran J, Itoh T, Reddy UR, Chen M, Alnemri ES, Pleasure D: Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP. J Neurochem. 1999, 73: 568-577. 10.1046/j.1471-4159.1999.0730568.x.CrossRefPubMed

31.

Kawanokuchi J, Mizuno T, Kato H, Mitsuma N, Suzumura A: Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system. Neuropharmacology. 2004, 46: 734-742. 10.1016/j.neuropharm.2003.11.007.CrossRefPubMed

32.

Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ: Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells. Am J Physiol Endocrinol Metab. 2009, 296: E559-566. 10.1152/ajpendo.90770.2008.CrossRefPubMed

33.

Meager A: Quantification of interferons by anti-viral assays and their standardization. Lymphokines and Interferons--A Practical Approach. Edited by: Clemens MJ, Morris AG, Gearing AJH. 1987, Oxford: IRL, 129-147.

34.

Holohan C, Szegezdi E, Ritter T, O'Brien T, Samali A: Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J Cell Mol Med. 2008, 12: 591-606. 10.1111/j.1582-4934.2007.00191.x.PubMedCentralCrossRefPubMed

35.

Panaretakis T, Hjortsberg L, Tamm KP, Björklund AC, Joseph B, Grandér D: Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Mol Biol Cell. 2008, 19: 41-50. 10.1091/mbc.E07-04-0358.PubMedCentralCrossRefPubMed

36.

Sharf R, Meraro D, Azriel A, Thornton AM, Ozato K, Petricoin EF, Larner AC, Schaper F, Hauser H, Levi BZ: Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem. 1997, 272: 9785-9792. 10.1074/jbc.272.15.9785.CrossRefPubMed

37.

Bovolenta C, Driggers PH, Marks MS, Medin JA, Politis AD, Vogel SN, Levy DE, Sakaguchi K, Appella E, Coligan JE: Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci USA. 1994, 91: 5046-5050. 10.1073/pnas.91.11.5046.PubMedCentralCrossRefPubMed

38.

Au WC, Pitha PM: Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters. J Biol Chem. 2001, 276: 41629-41637. 10.1074/jbc.M105121200.CrossRefPubMed

39.

Ling PD, Warren MK, Vogel SN: Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol. 1985, 135: 1857-1863.PubMed

40.

Inaba K, Kitaura M, Kato T, Watanabe Y, Kawade Y, Muramatsu S: Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens. J Exp Med. 1986, 163: 1030-1035. 10.1084/jem.163.4.1030.CrossRefPubMed

41.

Satoh J, Paty DW, Kim SU: Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology. 1995, 45: 367-373.CrossRefPubMed

42.

Ransohoff RM, Devajyothi C, Estes ML, Babcock G, Rudick RA, Frohman EM, Barna BP: Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J Neuroimmunol. 1991, 33: 103-112. 10.1016/0165-5728(91)90054-B.CrossRefPubMed

43.

Lu HT, Riley JL, Babcock GT, Huston M, Stark GR, Boss JM, Ransohoff RM: Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. J Exp Med. 1995, 182: 1517-1525. 10.1084/jem.182.5.1517.CrossRefPubMed

44.

Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, Merkler D, Detje C, Gutcher I, Mages J, Lang R, Martin R, Gold R, Becher B, Brück , Kalinke U: Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 2008, 28: 675-686. 10.1016/j.immuni.2008.03.011.CrossRefPubMed

45.

Yen JH, Ganea D: Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood. 2009, 114: 1344-1354. 10.1182/blood-2008-12-196592.PubMedCentralCrossRefPubMed

46.

Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F: T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol. 2009, 65: 499-509. 10.1002/ana.21652.CrossRefPubMed

47.

Driggers PH, Ennist DL, Gleason SL, Mak WH, Marks MS, Levi BZ, Flanagan JR, Appella E, Ozato K: An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA. 1990, 87: 3743-3747. 10.1073/pnas.87.10.3743.PubMedCentralCrossRefPubMed

48.

Tamura T, Ozato K: ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interferon Cytokine Res. 2002, 22: 145-152. 10.1089/107999002753452755.CrossRefPubMed

49.

Wang IM, Contursi C, Masumi A, Ma X, Trinchieri G, Ozato K: An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol. 2000, 165: 271-279.CrossRefPubMed

50.

Liu J, Guan X, Tamura T, Ozato K, Ma X: Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem. 2004, 279: 55609-55617. 10.1074/jbc.M406565200.CrossRefPubMed

51.

Xiong H, Zhu C, Li H, Chen F, Mayer L, Ozato K, Unkeless JC, Plevy SE: Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem. 2003, 278: 2271-2277. 10.1074/jbc.M209583200.CrossRefPubMed

52.

Contursi C, Wang IM, Gabriele L, Gadina M, O'Shea J, Morse HC, Ozato K: IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages. Proc Natl Acad Sci USA. 2000, 97: 91-96. 10.1073/pnas.97.1.91.PubMedCentralCrossRefPubMed

53.

Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring JF, Bachmann MF, Zinkemagel RM, Morse HC, Ozato K, Horak I: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 1996, 87: 307-317. 10.1016/S0092-8674(00)81348-3.CrossRefPubMed

54.

Scheller M, Foerster J, Heyworth CM, Waring JF, Lohler J, Gilmore GL, Shadduck RK, Dexter TM, Horak I: Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood. 1999, 94: 3764-3771.PubMed

55.

Huang W, Zhu C, Wang H, Horvath E, Eklund EA: The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells. J Biol Chem. 2008, 283: 7921-7935. 10.1074/jbc.M706710200.CrossRefPubMed

56.

Gabriele L, Phung J, Fukumoto J, Segal D, Wang IM, Giannakakou P, Giese NA, Ozato K, Morse HC: Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med. 1999, 190: 411-421. 10.1084/jem.190.3.411.PubMedCentralCrossRefPubMed

57.

Liu K, Abrams SI: Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma. J Immunol. 2003, 170: 6329-6337.CrossRefPubMed

58.

Kirchhoff S, Hauser H: Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis. Oncogene. 1999, 18: 3725-3736. 10.1038/sj.onc.1202704.CrossRefPubMed

59.

Mebratu YA, Dickey BF, Evans C, Tesfaigzi Y: The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death. J Cell Biol. 2008, 183: 429-439. 10.1083/jcb.200801186.PubMedCentralCrossRefPubMed

Title: Cooperative contributions of Interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells
Authors: Makoto Horiuchi
Aki Itoh
David Pleasure
Keiko Ozato
Takayuki Itoh
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Journal of Neuroinflammation / Issue 1/2011
Electronic ISSN: 1742-2094
DOI: https://doi.org/10.1186/1742-2094-8-8

At a glance: The STEP trials

Springer Medicine

Cooperative contributions of Interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Neuroinflammation induces glial aromatase expression in the uninjured songbird brain

A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children

CRP gene variation affects early development of Alzheimer's disease-related plaques

Peripheral leukocyte counts and outcomes after intracerebral hemorrhage

Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA

Transcellular migration of neutrophil granulocytes through the blood-cerebrospinal fluid barrier after infection with Streptococcus suis